SMALL CAP IDEAS: Hvivo helps big pharma amidst 'tripledemic'

Hvivo, formerly known as Open Orphan , is at the very heart of the latest advances - not as a vaccine maker, but helping drug developers assess the efficacy of their RSV treatments.